Two Sigma Advisers, LP
- SEC CIK
- 0001478735
- Latest filing
- Aug 14, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Two Sigma Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −604,540−100.0% | Sold out | Holders |
| Q4 2025 | 604,540 | $466.6M | 0.9% | −321,660−34.7% | Reduced | Holders |
| Q3 2025 | 926,200 | $520.8M | 1.0% | −12,300−1.3% | Reduced | Holders |
| Q2 2025 | 938,500 | $492.7M | 1.0% | +384,700+69.5% | Added | Holders |
| Q1 2025 | 553,800 | $351.2M | 0.8% | +553,800 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −900−100.0% | Sold out | Holders |
| Q3 2024 | 900 | $946.1K | <0.1% | −100−10.0% | Reduced | Holders |
| Q2 2024 | 1,000 | $1.05M | <0.1% | +1,000 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −12,900−100.0% | Sold out | Holders |
| Q4 2023 | 12,900 | $11.3M | <0.1% | −230,000−94.7% | Reduced | Holders |
| Q3 2023 | 242,900 | $199.9M | 0.5% | −56,400−18.8% | Reduced | Holders |
| Q2 2023 | 299,300 | $215.1M | 0.5% | +89,500+42.7% | Added | Holders |
| Q1 2023 | 209,800 | $172.4M | 0.4% | +161,300+332.6% | Added | Holders |
| Q4 2022 | 48,500 | $35.0M | 0.1% | −67,400−58.2% | Reduced | Holders |
| Q3 2022 | 115,900 | $79.8M | 0.2% | −163,100−58.5% | Reduced | Holders |
| Q2 2022 | 279,000 | $164.9M | 0.5% | −210,200−43.0% | Reduced | Holders |
| Q1 2022 | 489,200 | $341.7M | 0.9% | +100,700+25.9% | Added | Holders |
| Q4 2021 | 388,500 | $245.3M | 0.6% | +388,500 | New | Holders |